Technology and Equipment

Antibody drug conjugates offer a great deal of potential for drug targeting, but what’s the best way of linking drugs and antibodies?

VR is creating a buzz, but is it a game changer or gimmick?

Dr. Bernhard Hladik from SCHOTT breaks down the delamination phenomenon and describes how pharma manufacturers can effectively fight back.

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?

AAV vectors are a promising tool for gene therapy and regenerative medicine, but only if they can be manufactured efficiently

A “smart” synthetic patch uses live pancreatic cells to painlessly deliver insulin through microneedles – on demand

This application note explores the use of the Morphologi G3-ID for Morphologically-Directed Raman spectroscopy (MDRS) to identify and analyze contaminants including protein aggregates present in a stressed sample of lysozyme, and to compare particles held in suspension within a thin path wet cell with those collected on a filter membrane.

This application note provides an example of how Archimedes can be used to detect and quantify the formation of protein sub-visible particles and the introduction of silicone oil droplets, in response to shear stress.

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Pharma suppliers are teaming up to take ready-to-use technology to the next level.